Comparative Pharmacology
Head-to-head clinical analysis: DELFLEX W DEXTROSE 4 25 LOW MAGNESIUM IN PLASTIC CONTAINER versus INPERSOL ZM W DEXTROSE 1 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DELFLEX W DEXTROSE 4 25 LOW MAGNESIUM IN PLASTIC CONTAINER versus INPERSOL ZM W DEXTROSE 1 5 IN PLASTIC CONTAINER.
DELFLEX W/ DEXTROSE 4.25% LOW MAGNESIUM IN PLASTIC CONTAINER vs INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Delflex with Dextrose 4.25% Low Magnesium is a peritoneal dialysis solution that uses dextrose as an osmotic agent to create a concentration gradient across the peritoneal membrane, allowing for the removal of uremic toxins and excess fluid via ultrafiltration. The low magnesium concentration (0.25 mEq/L) helps prevent hypermagnesemia in patients with renal failure.
Inpersol-ZM w/ Dextrose 1.5% is a peritoneal dialysis solution that acts by creating a concentration gradient across the peritoneal membrane. The dextrose component provides an osmotic driving force that promotes ultrafiltration and removal of waste products (e.g., urea, creatinine) and excess electrolytes from the blood into the dialysate fluid, which is then drained from the peritoneal cavity. The electrolyte composition (sodium, chloride, calcium, magnesium, lactate) helps correct acid-base and electrolyte imbalances.
Intraperitoneal administration: 2 L per exchange, 4 exchanges daily. Dextrose concentration (1.5%, 2.5%, or 4.25%) determined by ultrafiltration needs. Low magnesium formulation selected based on serum magnesium levels.
250 mL to 2 L intraperitoneally, instilled over 10-20 minutes, dwell for 4-6 hours, then drain. Typically 4 exchanges per day.
None Documented
None Documented
Intraperitoneal dextrose: absorption half-life ~1.5-2 hours; elimination of absorbed glucose follows endogenous glucose kinetics (t1/2 ~1-2 hours). Clinical note: Continuous dwell results in steady-state concentrations.
Not applicable systemically; dextrose half-life is minutes due to rapid cellular uptake. In peritoneal dialysis, the half-life of glucose in the peritoneal cavity is approximately 30-60 minutes due to absorption into bloodstream.
Primarily renal (peritoneal clearance): ~60-80% of glucose absorbed is metabolized; dextrose metabolites (CO2, water) excreted via lungs and kidneys. Magnesium and other electrolytes are removed via peritoneal dialysis; net elimination varies with dialysis prescription.
Renal: 100% (dialysis fluid containing dextrose is removed directly; glucose is metabolized and not excreted unchanged). Dextrose undergoes cellular metabolism to CO2 and water.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution